- Home
- FLEX vs BDX Comparison
FLEX vs BDX Comparison
Compare FLEX & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLEX | BDX |
|---|---|---|
| Founded | 1990 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.9B | 43.0B |
| IPO Year | 1997 | 1998 |
Fundamental Metrics
Financial Performance| Metric | FLEX | BDX |
|---|---|---|
| Price | $117.45 | $170.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | $66.89 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 4.8M | 1.6M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | ★ 10.43 | N/A |
| EPS | ★ 0.76 | 0.25 |
| Revenue | ★ $28,679,925,000.00 | $21,840,000,000.00 |
| Revenue This Year | $8.14 | N/A |
| Revenue Next Year | $6.28 | $3.02 |
| P/E Ratio | ★ $48.82 | $662.48 |
| Revenue Growth | ★ 18.95 | 8.24 |
| 52 Week Low | $47.83 | $140.11 |
| 52 Week High | $166.86 | $213.08 |
Technical Indicators
Market Signals| Indicator | FLEX | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 42.16 | 66.45 |
| Support Level | $111.38 | $163.44 |
| Resistance Level | $131.68 | $196.05 |
| Average True Range (ATR) | 7.90 | 4.08 |
| MACD | -0.85 | 1.17 |
| Stochastic Oscillator | 45.40 | 86.01 |
Price Performance
Historical ComparisonAbout FLEX Flex Ltd.
Flex Ltd is the developed, end-to-end manufacturing partner of choice that helps a diverse customer base design, build, deliver and manage products that improve the world. The Company's full suite of specialized capabilities includes design and engineering, supply chain, manufacturing, and integrated services, plus a portfolio of power and cooling products. Its reportable segments includes Integrated Technology Solutions, Regulated Manufacturing Solutions, and Cloud and Power Infrastructure.
About BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.